Differences in Imaging Characteristics of HPV-Positive and HPV-Negative Oropharyngeal Cancers: A Blinded Matched-Pair Analysis

REFERENCES

1. 1.↵
   1. Chaturvedi AK,
   2. Engels EA,
   3. Anderson WF,
   4. et al

   . Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612–19

   Abstract/FREE Full Text
2. 2.
   1. Carvalho AL,
   2. Nishimoto IN,
   3. Califano JA,
   4. et al

   . Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806–16

   CrossRefPubMedWeb of Science
3. 3.
   1. Shiboski CH,
   2. Schmidt BL,
   3. Jordan RC

   . Tongue and tonsil carcinoma: increasing trends in the US population ages 20–44 years. Cancer 2005;103:1843–49

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Sturgis EM,
   2. Ang KK

   . The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw 2011;9:665–73

   Abstract/FREE Full Text
5. 5.↵
   1. Sturgis EM,
   2. Cinciripini PM

   . Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429–35

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Ang KK,
   2. Harris J,
   3. Wheeler R,
   4. et al

   . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Dahlstrom KR,
   2. Li G,
   3. Tortolero-Luna G,
   4. et al

   . Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 2011;33:847–55

   CrossRefPubMed
8. 8.
   1. D'Souza G,
   2. Kreimer AR,
   3. Viscidi R,
   4. et al

   . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–56

   CrossRefPubMedWeb of Science
9. 9.
   1. Gillison ML,
   2. D'Souza G,
   3. Westra W,
   4. et al

   . Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–20

   Abstract/FREE Full Text
10. 10.↵
    1. Ji X,
    2. Neumann AS,
    3. Sturgis EM,
    4. et al

    . p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis 2008;29:875–79

    Abstract/FREE Full Text
11. 11.↵
    1. Klussmann JP,
    2. Mooren JJ,
    3. Lehnen M,
    4. et al

    . Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009;15:1779–86

    Abstract/FREE Full Text
12. 12.↵
    1. Marur S,
    2. D'Souza G,
    3. Westra WH,
    4. et al

    . HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781–89

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Goldenberg D,
    2. Begum S,
    3. Westra WH,
    4. et al

    . Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008;30:898–903

    CrossRefPubMed
14. 14.↵
    1. Flanagan PM,
    2. Roland NJ,
    3. Jones AS

    . Cervical node metastases presenting with features of branchial cysts. J Laryngol Otol 1994;108:1068–71

    PubMed
15. 15.
    1. Gourin CG,
    2. Johnson JT

    . Incidence of unsuspected metastases in lateral cervical cysts. Laryngoscope 2000;110:1637–41

    CrossRefPubMed
16. 16.
    1. Regauer S,
    2. Mannweiler S,
    3. Anderhuber W,
    4. et al

    . Cystic lymph node metastases of squamous cell carinoma of Waldeyer's ring origin. Br J Cancer 1999;79:1437–42

    CrossRefPubMed
17. 17.↵
    1. Thompson LD,
    2. Heffner DK

    . The clinical importance of cystic squamous cell carcinomas in the neck: a study of 136 cases. Cancer 1998;82:944–56

    CrossRefPubMed
18. 18.↵
    1. Myers JN,
    2. Greenberg JS,
    3. Mo V,
    4. et al

    . Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001;92:3030–36

    CrossRefPubMedWeb of Science
19. 19.
    1. Wenzel S,
    2. Sagowski C,
    3. Kehrl W,
    4. et al

    . The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 2004;261:270–75

    CrossRefPubMed
20. 20.
    1. Iyer NG,
    2. Kim L,
    3. Nixon IJ,
    4. et al

    . Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation. Head Neck 2012 doi: 10.1002/hed.23071
21. 21.↵
    1. Olsen KD,
    2. Caruso M,
    3. Foote RL,
    4. et al

    . Primary head and neck cancer: histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg 1994;120:1370–74

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Martinez I,
    2. Wang J,
    3. Hobson KF,
    4. et al

    . Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer 2007;43:415–32

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Weinberger PM,
    2. Yu Z,
    3. Haffty BG,
    4. et al

    . Molecular classification identifies a subset of human papillomavirus—associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24:736–47

    Abstract/FREE Full Text
24. 24.↵
    1. Kumar B,
    2. Cordell KG,
    3. Lee JS,
    4. et al

    . EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;26:3128–37

    Abstract/FREE Full Text
25. 25.↵
    1. Hudgins PA,
    2. Gillison M

    . Second branchial cleft cyst: not!! AJNR Am J Neuroradiol 2009;9:1628–29